-
Integrated care for diabetes and eye health: A global compendium of good practice. Melbourne, Australia, 2018.
Authored and Compiled by:
The Fred Hollows Foundation, and in partnership with: Helen ...
WedAMUTCE_September+0000RSepAMUTC_th+00:000
-
A limited telephone intervention can improve significantly participation in retinopathy screening in a minority, low-income population. This intervention influenced risk perceptions about diabetes complications. ...
ThuAMUTCE_February+0000RFebAMUTC_th+00:001
-
The Fred Hollows Foundation (FHF) as the lead representative of a consortium of non-government organisations (NGOs) — the International Agency for the Prevention of Blindness (IAPB), Sightsavers International, ...
MonPMUTCE_February+0000RFebPMUTC_st+00:001
-
By early 2014, it had become clear that rapid advances in anti-vascular endothelial growth factor (VEGF) therapies were revolutionizing the treatment of DME — and the field of ophthalmology. Recognizing ...
MonPMUTCE_February+0000RFebPMUTC_st+00:001
-
The International Agency for the Prevention of Blindness (IAPB) considers appropriate information as a vital resource in improving eye health. In resource-constrained settings especially, procurement decisions ...
MonPMUTCE_February+0000RFebPMUTC_st+00:001
-
Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world's health systems. Globally, the number of people with DR will grow from 126.6 million in ...
MonPMUTCE_February+0000RFebPMUTC_st+00:001
-
Everyone with diabetes is at risk of losing vision. Good control of blood glucose, blood pressure and blood lipids as well as timely treatment can reduce the incidence of eye disease and vision loss.
...
FriPMUTCE_December+0000RDecPMUTC_th+00:000
-
Diabetic retinopathy is a common complication of diabetes and a leading cause of visual impairment and blindness. Research has established the importance of blood glucose control to prevent development ...
MonAMUTCE_November+0000RNovAMUTC_th+00:000
-
Characterize the economic and quality of life burden of diabetic macular edema (DME) in Canadian patients. DME-related healthcare costs were determined over 6 months, and vision-related, and generic (EQ-5D) ...
ThuAMUTCE_February+0000RFebAMUTC_th+00:000
-
Context Annual eye screening for patients with diabetes mellitus is frequently proposed as a measure of quality of care. However, the benefit of annual vs less frequent screening intervals has not ...
WedAMUTCE_February+0000RFebAMUTC_th+00:000
-
Objectives
To assess the performance of digital imaging, compared with other modalities, in screening for and monitoring the development of diabetic retinopathy.
Design
All imaging was acquired ...
WedAMUTCE_February+0000RFebAMUTC_th+00:000
-
Summary
Objective: Diabetic retinopathy, which leads to macular oedema and retinal neovascularisation, is the leading cause of blindness among working age Americans. Research has demonstrated significant ...
WedAMUTCE_February+0000RFebAMUTC_th+00:000
-
As part of the Diabetic Retinopathy Barometer project we are asking healthcare professionals and people with diabetes to participate in a global survey to help us better understand awareness levels around ...
MonPMUTCE_February+0000RFebPMUTC_rd+00:000
-
Diabetic retinopathy is a leading cause of preventable blindness in the working age population, and is a feared complication of many people with diabetes. There are over 90 million people who currently ...
TuePMUTCE_February+0000RFebPMUTC_nd+00:001
-
Diabetic retinopathy (DR) is one of the leading causes of preventable sight loss in the world.
The personal, social and economic costs of sight loss are well recognised, with strong evidence that ...
WedAMUTCE_February+0000RFebAMUTC_th+00:000
-
Screening for Diabetic Retinopathy in Europe – Impact of new technologies"
EASDec Scientific Meeting and Posters
23/06/16 - 25/06/16
-
View more results
